Advertisement
Screener

ENVERIC BIOSCIENCES, INC. (ENVB) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ENVERIC BIOSCIENCES, INC. Financing Cash Flow

ENVERIC BIOSCIENCES, INC. (ENVB) reported Financing Cash Flow of $8.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14

  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $5.84M, a 1201.50% increase year-over-year.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $2.50M, a 43.73% decline year-over-year.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.69M, a 480.25% increase year-over-year.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.99M, a 478.02% increase year-over-year.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2025 was $10.58M, a 37.86% increase from fiscal 2024.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2024 was $7.67M.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$1.34M, a 107.39% decline from fiscal 2022.
  • ENVERIC BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $18.18M, a 26.99% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-06-30$5.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$8.35M
10-Q · filed 2026-08-14
$11.04M
derived: sum of 3 quarters · filed 2026-08-14
$14.03M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$2.50M
10-Q · filed 2026-05-15
$5.19M
derived: sum of 2 quarters · filed 2026-05-15
$8.18M
derived: sum of 3 quarters · filed 2026-05-15
$8.63M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$2.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$5.68M
derived: sum of 2 quarters · filed 2026-03-27
$6.13M
derived: sum of 3 quarters · filed 2026-08-14
$10.58M
10-K · filed 2026-03-27
2025-09-30$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$3.44M
derived: sum of 2 quarters · filed 2026-08-14
$7.89M
10-Q · filed 2025-11-14
$8.35M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$449.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$4.90M
10-Q · filed 2026-08-14
$5.36M
derived: sum of 3 quarters · filed 2026-08-14
$5.88M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$4.45M
10-Q · filed 2026-05-15
$4.91M
derived: sum of 2 quarters · filed 2026-05-15
$5.43M
derived: sum of 3 quarters · filed 2026-05-15
$5.46M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$463.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$981.13K
derived: sum of 2 quarters · filed 2026-03-27
$1.02M
derived: sum of 3 quarters · filed 2026-03-27
$7.67M
10-K · filed 2026-03-27
2024-09-30$517.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$552.12K
derived: sum of 2 quarters · filed 2025-11-14
$7.21M
10-Q · filed 2025-11-14
$7.02M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$34.43K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$6.69M
10-Q · filed 2025-08-14
$6.51M
derived: sum of 3 quarters · filed 2025-08-14
$6.40M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$6.66M
10-Q · filed 2025-05-14
$6.47M
derived: sum of 2 quarters · filed 2025-05-14
$6.37M
derived: sum of 3 quarters · filed 2025-05-14
2023-12-31-$186.08K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
-$291.08K
derived: sum of 2 quarters · filed 2025-03-28
-$1.34M
10-K · filed 2025-03-28
2023-09-30-$105.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$1.16M
10-Q · filed 2024-11-14
2023-06-30-$1.05M
10-Q · filed 2024-08-12
2022-12-31-$1.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$7.82M
derived: sum of 2 quarters · filed 2024-03-26
$8.78M
derived: sum of 3 quarters · filed 2024-03-26
$18.18M
10-K · filed 2024-03-26
2022-09-30$7.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$8.78M
derived: sum of 2 quarters · filed 2023-11-13
$18.18M
10-Q · filed 2023-11-13
$18.18M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$958.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$10.36M
10-Q · filed 2023-08-11
$10.36M
derived: sum of 3 quarters · filed 2023-08-11
$10.36M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$9.40M
10-Q · filed 2023-05-15
$9.40M
derived: sum of 2 quarters · filed 2023-06-09
$9.40M
derived: sum of 3 quarters · filed 2023-06-09
$9.42M
derived: sum of 4 quarters · filed 2023-06-09
2021-12-31$7.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-09
-$2.00
derived: sum of 2 quarters · filed 2023-06-09
$17.93K
derived: sum of 3 quarters · filed 2023-06-09
$24.90M
10-K/A · filed 2023-06-09
2021-09-30-$9.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$17.92K
derived: sum of 2 quarters · filed 2022-11-14
$24.90M
10-Q · filed 2022-11-14
$28.50M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$17.93K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$24.90M
10-Q · filed 2022-08-12
$28.50M
derived: sum of 3 quarters · filed 2022-08-12
$28.73M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$24.88M
10-Q · filed 2022-05-13
$28.48M
derived: sum of 2 quarters · filed 2022-05-13
$28.71M
derived: sum of 3 quarters · filed 2022-05-13
$30.52M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$3.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$3.83M
derived: sum of 2 quarters · filed 2022-03-31
$5.64M
derived: sum of 3 quarters · filed 2022-03-31
$5.53M
10-K · filed 2022-03-31
2020-09-30$227.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$2.04M
derived: sum of 2 quarters · filed 2021-11-15
$1.93M
10-Q · filed 2021-11-15
$6.31M
10-Q · filed 2020-11-16
$560.53K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
$1.70M
10-Q · filed 2021-08-13
$4.56M
10-Q · filed 2020-08-14
$333.03K
derived: sum of 3 quarters · filed 2021-08-13
$333.03K
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$107.71K
10-Q · filed 2021-05-17
$3.17M
10-Q · filed 2020-05-15
-$1.48M
derived: sum of 2 quarters · filed 2021-05-17
-$1.48M
derived: sum of 3 quarters · filed 2021-05-17
-$995.54K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01
-$1.37M
derived: sum of 2 quarters · filed 2021-04-01
-$887.82K
derived: sum of 3 quarters · filed 2021-04-01
$560.00K
10-K · filed 2021-04-01
$1.80M
10-K · filed 2020-03-25
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
$483.84K
derived: sum of 2 quarters · filed 2020-11-16
$1.93M
10-Q · filed 2020-11-16
$1.35M
10-Q · filed 2019-11-08
$2.22M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$483.84K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$1.93M
10-Q · filed 2020-08-14
$2.22M
derived: sum of 3 quarters · filed 2020-08-14
$7.23M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$1.45M
10-Q · filed 2020-05-15
$1.74M
derived: sum of 2 quarters · filed 2020-08-12
$6.75M
derived: sum of 3 quarters · filed 2020-08-12
$5.73M
derived: sum of 4 quarters · filed 2020-08-12
2018-12-31$292.64K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12
$5.30M
derived: sum of 2 quarters · filed 2020-08-12
$4.28M
derived: sum of 3 quarters · filed 2020-08-12
$2.69M
10-K/A · filed 2020-08-12
2018-09-30$5.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$3.99M
derived: sum of 2 quarters · filed 2019-11-08
$2.40M
10-Q · filed 2019-11-08
$7.49M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$2.60M
10-Q · filed 2019-08-14
$2.48M
derived: sum of 3 quarters · filed 2019-08-14
$2.38M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$1.59M
10-Q · filed 2019-05-14
$3.50M
derived: sum of 2 quarters · filed 2019-05-14
$3.40M
derived: sum of 3 quarters · filed 2019-05-14
$3.49M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$5.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$4.99M
derived: sum of 2 quarters · filed 2019-03-26
$5.08M
derived: sum of 3 quarters · filed 2019-03-26
$6.41M
10-K · filed 2019-03-26
$7.05M
10-K · filed 2018-04-02
2017-09-30-$98.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$9.55K
derived: sum of 2 quarters · filed 2018-11-14
$1.33M
10-Q · filed 2018-11-14
$1.97M
10-Q · filed 2017-11-13
$657.30K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$88.90K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$1.43M
10-Q · filed 2018-08-14
$2.06M
10-Q · filed 2017-08-14
$755.75K
derived: sum of 3 quarters · filed 2018-08-14
$5.05M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$1.34M
10-Q · filed 2018-05-15
$666.85K
derived: sum of 2 quarters · filed 2018-05-15
$4.96M
derived: sum of 3 quarters · filed 2018-05-15
$9.89M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$669.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$3.63M
derived: sum of 2 quarters · filed 2018-04-02
$8.56M
derived: sum of 3 quarters · filed 2018-04-02
$8.80M
10-K · filed 2018-04-02
2016-09-30$4.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$9.23M
derived: sum of 2 quarters · filed 2017-11-13
$9.47M
10-Q · filed 2017-11-13
$10.29M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30$4.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$5.17M
10-Q · filed 2017-08-14
$6.00M
derived: sum of 3 quarters · filed 2017-08-14
$6.25M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$241.45K
10-Q · filed 2016-05-16
$1.07M
derived: sum of 2 quarters · filed 2017-04-04
$1.32M
derived: sum of 3 quarters · filed 2017-04-04
$6.35M
derived: sum of 4 quarters · filed 2017-04-04
2015-12-31$826.41K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04
$1.08M
derived: sum of 2 quarters · filed 2017-04-04
$6.24M
10-KT · filed 2016-03-15
$6.24M
10-K/A · filed 2017-04-04
2015-09-30$250.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$5.28M
derived: sum of 2 quarters · filed 2016-11-14
$5.41M
10-Q · filed 2016-11-14
$5.41M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$5.03M
10-Q · filed 2015-08-18
$5.16M
10-Q · filed 2016-08-12
$5.16M
derived: sum of 3 quarters · filed 2016-05-16
$5.16M
derived: sum of 4 quarters · filed 2016-05-16
2015-03-31$125.00K
10-Q · filed 2016-05-16
$125.00K
derived: sum of 2 quarters · filed 2016-05-16
$125.00K
derived: sum of 3 quarters · filed 2016-05-16
$125.00K
10-KT · filed 2016-03-15
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$0.00
derived: sum of 2 quarters · filed 2015-03-31
$125.00K
derived: sum of 3 quarters · filed 2015-08-18
$48.00K
10-K · filed 2015-03-31
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$125.00K
derived: sum of 2 quarters · filed 2015-08-18
$48.00K
10-Q · filed 2014-11-14
$175.00K
derived: sum of 4 quarters · filed 2015-08-18
2014-06-30$125.00K
10-Q · filed 2015-08-18
$48.00K
10-Q · filed 2014-08-11
$175.00K
derived: sum of 3 quarters · filed 2015-08-18
$178.50K
derived: sum of 4 quarters · filed 2015-08-18
2014-03-31$50.00K
10-Q · filed 2015-05-14
$50.00K
derived: sum of 2 quarters · filed 2015-05-14
$53.50K
derived: sum of 3 quarters · filed 2015-05-14
$10.00K
10-KT · filed 2016-03-15
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$3.50K
derived: sum of 2 quarters · filed 2015-03-31
$8.50K
derived: sum of 3 quarters · filed 2015-03-31
$20.50K
10-K · filed 2015-03-31
2013-09-30$3.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$8.50K
derived: sum of 2 quarters · filed 2014-11-14
$20.50K
10-Q · filed 2014-11-14
$23.50K
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$5.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-11
$17.00K
10-Q · filed 2014-08-11
$20.00K
derived: sum of 3 quarters · filed 2014-08-11
2013-03-31$12.00K
10-Q/A · filed 2014-05-08
$15.00K
derived: sum of 2 quarters · filed 2014-05-08
2012-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$8.00K
10-K · filed 2014-03-28
2012-09-30$5.00K
10-Q · filed 2013-11-06
2011-12-31$2.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$47.45K
10-K · filed 2013-02-28
2011-09-30$44.60K
10-Q · filed 2012-11-13
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-07
$40.00K
10-K · filed 2012-03-07
2010-09-30$40.00K
10-Q · filed 2011-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
SYNLOGIC, INC. (SYBX)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Pulmatrix, Inc. (PULM)United States$0.006B
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
EXICURE, INC. (XCUR)United States$0.008B-1.54